• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 Sigmoid 模型预测国家层面的抗菌药物耐药性传播。

Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level.

机构信息

National Institute for Antibiotic Resistance and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

University of Adelaide, Adelaide, Australia.

出版信息

Euro Surveill. 2020 Jun;25(23). doi: 10.2807/1560-7917.ES.2020.25.23.1900387.

DOI:10.2807/1560-7917.ES.2020.25.23.1900387
PMID:32553060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403637/
Abstract

BackgroundThe spread of antimicrobial resistance (AMR) is of worldwide concern. Public health policymakers and pharmaceutical companies pursuing antibiotic development require accurate predictions about the future spread of AMR.AimWe aimed to identify and model temporal and geographical patterns of AMR spread and to predict future trends based on a slow, intermediate or rapid rise in resistance.MethodsWe obtained data from five antibiotic resistance surveillance projects spanning the years 1997 to 2015. We aggregated the isolate-level or country-level data by country and year to produce country-bacterium-antibiotic class triads. We fitted both linear and sigmoid models to these triads and chose the one with the better fit. For triads that conformed to a sigmoid model, we classified AMR progression into one of three characterising paces: slow, intermediate or fast, based on the sigmoid slope. Within each pace category, average sigmoid models were calculated and validated.ResultsWe constructed a database with 51,670 country-year-bacterium-antibiotic observations, grouped into 7,440 country-bacterium-antibiotic triads. A total of 1,037 triads (14%) met the inclusion criteria. Of these, 326 (31.4%) followed a sigmoid (logistic) pattern over time. Among 107 triads for which both sigmoid and linear models could be fit, the sigmoid model was a better fit in 84%. The sigmoid model deviated from observed data by a median of 6.5%; the degree of deviation was related to the pace of spread.ConclusionWe present a novel method of describing and predicting the spread of antibiotic-resistant organisms.

摘要

背景

抗菌药物耐药性(AMR)的传播引起了全球关注。公共卫生政策制定者和从事抗生素开发的制药公司都需要对 AMR 的未来传播进行准确预测。

目的

我们旨在识别和建模 AMR 传播的时间和地理模式,并根据耐药性的缓慢、中等或快速上升来预测未来趋势。

方法

我们从五个抗生素耐药性监测项目中获取了 1997 年至 2015 年的数据。我们根据国家和年份将分离株水平或国家水平的数据汇总,生成国家-细菌-抗生素类别三联体。我们对这些三联体拟合了线性和 S 型模型,并选择了拟合效果更好的模型。对于符合 S 型模型的三联体,我们根据 S 型斜率将 AMR 进展分为缓慢、中等或快速三种特征性速度之一。在每个速度类别中,计算并验证平均 S 型模型。

结果

我们构建了一个包含 51670 个国家-年份-细菌-抗生素观察值的数据库,分为 7440 个国家-细菌-抗生素三联体。共有 1037 个三联体(14%)符合纳入标准。其中,326 个(31.4%)随着时间的推移呈现 S 型(逻辑)模式。在可以拟合 S 型和线性模型的 107 个三联体中,S 型模型在 84%的情况下拟合效果更好。S 型模型与观察数据的偏差中位数为 6.5%;偏差程度与传播速度有关。

结论

我们提出了一种描述和预测抗生素耐药性生物传播的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/d5902952c899/1900387-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/f565de2ab8c9/1900387-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/5fd9ff5163a0/1900387-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/d5902952c899/1900387-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/f565de2ab8c9/1900387-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/5fd9ff5163a0/1900387-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b90/7403637/d5902952c899/1900387-f3.jpg

相似文献

1
Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level.利用 Sigmoid 模型预测国家层面的抗菌药物耐药性传播。
Euro Surveill. 2020 Jun;25(23). doi: 10.2807/1560-7917.ES.2020.25.23.1900387.
2
A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance.印度动物健康和药物使用情况综述及其与抗微生物药物耐药性的可能联系。
Antimicrob Resist Infect Control. 2020 Jul 8;9(1):103. doi: 10.1186/s13756-020-00760-3.
3
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study.29 个欧洲国家血流感染中抗菌药物耐药率的年龄和性别差异:一项观察性研究。
PLoS Med. 2024 Mar 14;21(3):e1004301. doi: 10.1371/journal.pmed.1004301. eCollection 2024 Mar.
4
[Antimicrobial resistance: it is a global crisis, "a slow tsunami"].[抗微生物药物耐药性:这是一场全球危机,“一场缓慢的海啸”]
Ig Sanita Pubbl. 2019 Nov-Dec;75(6):429-450.
5
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.按抗生素使用量计算抗生素耐药性的经济成本,以用于评估影响抗生素使用的干预措施。
Antimicrob Resist Infect Control. 2018 Aug 9;7:98. doi: 10.1186/s13756-018-0384-3. eCollection 2018.
6
Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.抗生素耐药性——促进新技术的行动:2005年12月12日至13日在英国伯明翰举行的欧盟政府间会议报告
J Antimicrob Chemother. 2006 Sep;58 Suppl 1:i3-i22. doi: 10.1093/jac/dkl373. Epub 2006 Sep 26.
7
A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption.基于抗菌药物耐药水平与使用量之间关系的细菌耐药发展预测数学模型
J Glob Antimicrob Resist. 2017 Mar;8:148-156. doi: 10.1016/j.jgar.2016.11.010. Epub 2017 Feb 3.
8
Surveillance systems to monitor antimicrobial resistance in : a global, systematic review, 1 January 2012 to 27 September 2020.监测抗菌药物耐药性的监测系统:2012 年 1 月 1 日至 2020 年 9 月 27 日的全球系统评价。
Euro Surveill. 2022 May;27(18). doi: 10.2807/1560-7917.ES.2022.27.18.2100917.
9
Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.全球抗菌药物耐药性驱动因素:在人与动物接触界面的生态国家级研究。
Lancet Planet Health. 2023 Apr;7(4):e291-e303. doi: 10.1016/S2542-5196(23)00026-8.
10
A hierarchical Bayesian latent class mixture model with censorship for detection of linear temporal changes in antibiotic resistance.一种带有删失的分层贝叶斯潜在类混合模型,用于检测抗生素耐药性的线性时间变化。
PLoS One. 2020 Jan 31;15(1):e0220427. doi: 10.1371/journal.pone.0220427. eCollection 2020.

引用本文的文献

1
Changing climate and socioeconomic factors contribute to global antimicrobial resistance.气候变化和社会经济因素促成了全球抗菌素耐药性。
Nat Med. 2025 Apr 28. doi: 10.1038/s41591-025-03629-3.
2
The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance.人工智能和机器学习在预测及对抗抗菌药物耐药性方面的作用。
Comput Struct Biotechnol J. 2025 Jan 18;27:423-439. doi: 10.1016/j.csbj.2025.01.006. eCollection 2025.
3
Predicting future hospital antimicrobial resistance prevalence using machine learning.

本文引用的文献

1
Send more data: a systematic review of mathematical models of antimicrobial resistance.发送更多数据:抗菌药物耐药性数学模型的系统评价。
Antimicrob Resist Infect Control. 2018 Sep 29;7:117. doi: 10.1186/s13756-018-0406-1. eCollection 2018.
2
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.估算 2014 年抗生素耐药性大肠杆菌和肺炎克雷伯菌感染的数量:一项建模研究。
Lancet Glob Health. 2018 Sep;6(9):e969-e979. doi: 10.1016/S2214-109X(18)30278-X.
3
Estimating the burden of antimicrobial resistance: a systematic literature review.
使用机器学习预测未来医院抗菌药物耐药性的流行情况。
Commun Med (Lond). 2024 Oct 10;4(1):197. doi: 10.1038/s43856-024-00606-8.
4
Antibiotic Discovery and Resistance: The Chase and the Race.抗生素的发现与耐药性:追寻与竞赛
Antibiotics (Basel). 2022 Jan 30;11(2):182. doi: 10.3390/antibiotics11020182.
评估抗菌药物耐药负担:系统文献综述。
Antimicrob Resist Infect Control. 2018 Apr 25;7:58. doi: 10.1186/s13756-018-0336-y. eCollection 2018.
4
Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae.全球侵袭性大肠埃希菌和肺炎克雷伯菌分离株的抗菌药物耐药性预测。
Int J Infect Dis. 2018 Mar;68:50-53. doi: 10.1016/j.ijid.2018.01.011. Epub 2018 Feb 2.
5
Surveillance for control of antimicrobial resistance.监测以控制抗微生物药物耐药性。
Lancet Infect Dis. 2018 Mar;18(3):e99-e106. doi: 10.1016/S1473-3099(17)30485-1. Epub 2017 Nov 5.
6
Addressing the Unknowns of Antimicrobial Resistance: Quantifying and Mapping the Drivers of Burden.应对抗菌药物耐药性的未知挑战:量化和绘制负担驱动因素图谱。
Clin Infect Dis. 2018 Feb 1;66(4):612-616. doi: 10.1093/cid/cix765.
7
Life After USA300: The Rise and Fall of a Superbug.美国300之后的日子:一种超级细菌的兴衰
J Infect Dis. 2017 Feb 15;215(suppl_1):S71-S77. doi: 10.1093/infdis/jiw444.
8
The World Health Organization Global Action Plan for antimicrobial resistance.世界卫生组织抗微生物药物耐药性全球行动计划。
S Afr Med J. 2015 Apr 6;105(5):325. doi: 10.7196/samj.9644.
9
Modeling infectious disease dynamics in the complex landscape of global health.在全球健康复杂格局中建模传染病动态。
Science. 2015 Mar 13;347(6227):aaa4339. doi: 10.1126/science.aaa4339.
10
An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.一项正在进行的全国性干预措施,旨在遏制碳青霉烯类耐药肠杆菌科的传播。
Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4.